1 in 10 adults lives with diabetes.​
1 in 3 of them is at risk of vision loss from diabetic retinopathy.​

​Diabetic Retinopathy is largely preventable, yet it remains a leading cause of avoidable vision loss because screening does not scale. Dependence on specialists and complex workflows delays detection and leaves millions undiagnosed until late stages.

Medios DR AI enables scalable, point-of-care screening beyond specialist settings. It brings early detection into primary care and communities, systematically discovering new patients, accelerating referrals, and embedding eye screening into routine diabetes care at scale.